Prognostic Impact of the Increase in Cardiac Troponin Levels during Tafamidis Therapy in Patients with Transthyretin Cardiac Amyloidosis.

Makiko Nakamura Teruhiko Imamura Ryuichi UshijimaKoichiro Kinugawa

Published in: Journal of clinical medicine (2023)

The increase in cardiac troponin levels may be a reasonable surrogate marker of response to tafamidis therapy in patients with transthyretin cardiac amyloidosis.

Keyphrases

left ventricular
multiple myeloma
wild type
heart failure
stem cells
mesenchymal stem cells
bone marrow